Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-03-05
1993-06-15
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 18, 514 19, 514913, 514885, 544128, A61K 31535, A61K 3700, C07D41300
Patent
active
052198510
ABSTRACT:
The invention concerns novel renin-inhibitory compounds which contain a tetrahydroisoquinoline or similar heterocycle at the P.sub.3 position. These are useful for treating hypertension, congestive heart failure, glaucoma, hyperaldosteronism, and diseases caused by retroviruses including HTLV-I, -II and -III. Processes for preparing the compounds, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, or hyperaldosteronism.
REFERENCES:
patent: 4948793 (1990-08-01), Allison et al.
patent: 5063207 (1991-11-01), Doherty et al.
patent: 5134123 (1992-07-01), Branca et al.
patent: 5135914 (1992-08-01), Hamilton et al.
Bolis et al., J. Med. Chem., vol. 30, pp. 1729-1737 (1987).
Plattner et al. J. Med. Chem., vol. 31, No. 12, pp. 2277-2288 (1988).
Denkewalter et al., Progress in Drug Research, 1966, vol. 10, pp. 510-512 (1966).
Burger, Medicinal Chemistry, 1960, pp. 565-571, 578-581, 600-601.
Huber et al., J. Cardiovascular Pharmacology, 1987, 10 (Suppl. 7), pp. 554-558.
Hamilton Harriet W.
Patt William C.
Anderson Elizabeth M.
Griffin Ronald W.
Warner-Lambert & Company
LandOfFree
Tetrahydroisoquinoline-type renin inhibiting peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroisoquinoline-type renin inhibiting peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroisoquinoline-type renin inhibiting peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1042819